These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 1689712)

  • 1. Cytogenetic characterization of 20 lymphoblastoid lines derived from human individuals differing in bleomycin sensitivity.
    Hsu TC; Shillitoe EJ; Cherry LM; Lin Q; Schantz SP; Furlong C
    In Vitro Cell Dev Biol; 1990 Jan; 26(1):80-4. PubMed ID: 1689712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of cell cycle control in bleomycin-induced mutagen sensitivity.
    Cloos J; Temmink O; Ceelen M; Snel MH; Leemans CR; Braakhuis BJ
    Environ Mol Mutagen; 2002; 40(2):79-84. PubMed ID: 12203399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specificity of bleomycin-induced cytotoxic effects on ataxia telangiectasia lymphoid cell lines.
    Cohen MM; Simpson SJ; Pazos L
    Cancer Res; 1981 May; 41(5):1817-23. PubMed ID: 6163529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effects of vitamin E against bleomycin-induced genotoxicity in head and neck cancer patients in vitro.
    Trizna Z; Hsu TC; Schantz SP
    Anticancer Res; 1992; 12(2):325-7. PubMed ID: 1374597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytogenetic sensitivity of three Fanconi anemia heterozygotes to bleomycin and ionizing radiation.
    Barquinero JF; Barrios L; Ribas M; Egozcue J; Caballín MR
    Cancer Genet Cytogenet; 2001 Jan; 124(1):80-3. PubMed ID: 11165327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential susceptibility to chromatid breaks induced by bleomycin in sub-fertile and fertile bovines.
    Luna HS; Ferrari I; Luna H; McManus C; Padovani CR; Rumpf R
    Reprod Toxicol; 2004 Nov; 19(1):97-101. PubMed ID: 15336717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inherited susceptibility to bleomycin-induced chromatid breaks in cultured peripheral blood lymphocytes.
    Cloos J; Nieuwenhuis EJ; Boomsma DI; Kuik DJ; van der Sterre ML; Arwert F; Snow GB; Braakhuis BJ
    J Natl Cancer Inst; 1999 Jul; 91(13):1125-30. PubMed ID: 10393720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A parallel study of in vitro sensitivity to benzo[a]pyrene diol epoxide and bleomycin in lung carcinoma cases and controls.
    Wu X; Gu J; Amos CI; Jiang H; Hong WK; Spitz MR
    Cancer; 1998 Sep; 83(6):1118-27. PubMed ID: 9740076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential mutagen susceptibility in cultured lymphocytes of normal individuals and cancer patients.
    Hsu TC; Cherry LM; Samaan NA
    Cancer Genet Cytogenet; 1985 Aug; 17(4):307-13. PubMed ID: 2410094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microarray analysis of bleomycin-exposed lymphoblastoid cells for identifying cancer susceptibility genes.
    Cloos J; de Boer WP; Snel MH; van den Ijssel P; Ylstra B; Leemans CR; Brakenhoff RH; Braakhuis BJ
    Mol Cancer Res; 2006 Feb; 4(2):71-7. PubMed ID: 16513838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutagen sensitivity in humans. A comparison between two nomenclature systems for recording chromatid breaks.
    Hsu TC; Wu X; Trizna Z
    Cancer Genet Cytogenet; 1996 Apr; 87(2):127-32. PubMed ID: 8625258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytogenetic damage and cytokinetics in streptonigrin-treated human lymphocytes.
    Linscombe VA; Gollapudi BB; Sinha AK
    In Vitro Cell Dev Biol; 1991 Aug; 27A(8):603-5. PubMed ID: 1917777
    [No Abstract]   [Full Text] [Related]  

  • 13. DNA repair capacity correlates with mutagen sensitivity in lymphoblastoid cell lines.
    Wei Q; Spitz MR; Gu J; Cheng L; Xu X; Strom SS; Kripke ML; Hsu TC
    Cancer Epidemiol Biomarkers Prev; 1996 Mar; 5(3):199-204. PubMed ID: 8833620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro protective effects of chemopreventive agents against bleomycin-induced genotoxicity in lymphoblastoid cell lines and peripheral blood lymphocytes of head and neck cancer patients.
    Trizna Z; Schantz SP; Lee JJ; Spitz MR; Goepfert H; Hsu TC; Hong WK
    Cancer Detect Prev; 1993; 17(6):575-83. PubMed ID: 7506126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutagen sensitivity as a susceptibility marker for human hepatocellular carcinoma.
    Wu X; Gu J; Patt Y; Hassan M; Spitz MR; Beasley RP; Hwang LY
    Cancer Epidemiol Biomarkers Prev; 1998 Jul; 7(7):567-70. PubMed ID: 9681523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutagen sensitivity as a susceptibility marker for endometriosis.
    Lin J; Zhang X; Chen Y
    Hum Reprod; 2003 Oct; 18(10):2052-7. PubMed ID: 14507820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cytogenetic response of Fanconi's anemia lymphoblastoid cell lines to various clastogens.
    Cohen MM; Fruchtman CE; Simpson SJ; Martin AO
    Cytogenet Cell Genet; 1982; 34(3):230-40. PubMed ID: 6183057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carotenoids reduce the chromosomal damage induced by bleomycin in human cultured lymphocytes.
    Bianchi L; Tateo F; Pizzala R; Stivala LA; Grazia Verri M; Melli R; Santamaria L
    Anticancer Res; 1993; 13(4):1007-10. PubMed ID: 7688937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clastogenic interactions between lobeline sulfate and ethyl alcohol: a cytogenetic study.
    Brown NM; Trizna Z; Pathak S
    Anticancer Res; 1992; 12(5):1467-9. PubMed ID: 1280029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-(4-hydroxyphenyl) retinamide is anticlastogenic in human lymphoblastoid cell lines.
    Trizna Z; Benner SE; Shirley L; Furlong C; Hong WK
    Anticancer Res; 1993; 13(2):355-6. PubMed ID: 7685988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.